Recombinant multi-species FBLIM1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FBLIM1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein with an N-terminal filamin-binding domain, a central proline-rich domain, and, multiple C-terminal LIM domains. This protein localizes at cell junctions and may link cell adhesion structures to the actin cytoskeleton. This protein may be involved in the assembly and stabilization of actin-filaments and likely plays a role in modulating cell adhesion, cell morphology and cell motility. This protein also localizes to the nucleus and may affect cardiomyocyte differentiation after binding with the CSX/NKX2-5 transcription factor. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
The Alternative Names of target: FBLIM1,Filamin-binding LIM protein 1,FBLP-1,Migfilin, Mitogen-inducible 2-interacting protein (MIG2-interacting protein),CAL,FBLP1,FBLP-1

Target products collectionGo to FBLIM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2495-Ab-1/ GM-Tg-hg-IP2495-Ab-2 Human FBLIM1 protein Human
GM-Tg-rg-IP2495-Ab-1/ GM-Tg-rg-IP2495-Ab-2 Rat FBLIM1 protein Rat
GM-Tg-mg-IP2495-Ab-1/ GM-Tg-mg-IP2495-Ab-2 Mouse FBLIM1 protein Mouse
GM-Tg-cynog-IP2495-Ab-1/ GM-Tg-cynog-IP2495-Ab-2 Cynomolgus/Rhesus macaque FBLIM1 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2495-Ab-1/ GM-Tg-felg-IP2495-Ab-2 Feline FBLIM1 protein Feline
GM-Tg-cang-IP2495-Ab-1/ GM-Tg-cang-IP2495-Ab-2 Canine FBLIM1 protein Canine
GM-Tg-bovg-IP2495-Ab-1/ GM-Tg-bovg-IP2495-Ab-2 Bovine FBLIM1 protein Bovine
GM-Tg-equg-IP2495-Ab-1/ GM-Tg-equg-IP2495-Ab-2 Equine FBLIM1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2495-Ab-1/ GM-Tg-hg-IP2495-Ab-2; GM-Tg-rg-IP2495-Ab-1/ GM-Tg-rg-IP2495-Ab-2;
GM-Tg-mg-IP2495-Ab-1/ GM-Tg-mg-IP2495-Ab-2; GM-Tg-cynog-IP2495-Ab-1/ GM-Tg-cynog-IP2495-Ab-2;
GM-Tg-felg-IP2495-Ab-1/ GM-Tg-felg-IP2495-Ab-2; GM-Tg-cang-IP2495-Ab-1/ GM-Tg-cang-IP2495-Ab-2;
GM-Tg-bovg-IP2495-Ab-1/ GM-Tg-bovg-IP2495-Ab-2; GM-Tg-equg-IP2495-Ab-1/ GM-Tg-equg-IP2495-Ab-2
Products Name FBLIM1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FBLIM1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FBLIM1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.